Skip to main content
Donate
Login
IASLC's 50th Anniversary
IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
2023 Annual Report
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2023 Highlights
Research & Education
Research & Education
Publications, Resources & Guidelines
Publications, Resources & Guidelines
Guide to COVID-19 and Lung Cancer
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 1429 - 1440 items out of 2107 results
Press release
Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC
Press release
United Kingdom-Based Smoking Cessation Program Reports That 30 Percent of Support in a Lung Cancer Screening Program: The Yorkshire Enhanced Stop Smoking Study (YESS)
Press release
Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC
Press release
International Association for the Study of Lung Cancer Hosts World Conference on Lung Cancer Presidential Symposium Press Briefing on Monday, August 8, 2022
Press release
Sub-Lobar Surgery for Peripheral Non-Small Cell Lung Cancer Non-Inferior to Lobectomy
Press release
NADIM II Trial Provides Further Support for Neoadjuvant Chemoimmunotherapy for Patients with Resectable Non-Small Cell Lung Cancer
ILCN article
Mini Oral Session Examines Research Surrounding Patient Advocacy Issues
ILCN article
To Make Immunotherapy More Effective in Lung Cancer, Consider the Tumor Microenvironment
ILCN article
Oral Abstract Presentations to Focus on the Application of Multidisciplinary Care
ILCN article
Vienna’s Museums and Historical Sites Range from Cultural to Quirky
Podcast
WCLC 2022 Daily Highlights - August 8
Podcast
Destacados Diarios WCLC 2022 - 8 de Agosto (Presented in Spanish)
Pagination
First
First page
‹
Previous page
…
116
117
118
119
120
121
122
123
124
…
›
Next page
Last
Last page